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’INTRODUCTION
Paraquat (N,N-dimethyl-4,40-bipyridinium dichloride; PQ)
is a widely used herbicide due to its rapid eﬀect and quick
deactivation once in contact with soil. However, it is of great
toxicological importance and associated with a high mortality
rate during human exposure.
1 5 Epidemiological studies also
suggest that PQ exposure may increase the risk for Parkinson’s
disease.
6,7PQaccumulateswithhighconcentrationsinlung,liver
and kidney,
8,9 which causes the primary symptoms of PQ
toxicity,including respiration diﬃculty, hepatitis,and acute renal
failure, respectively.
10 PQ toxicity results from the overproduc-
tionofreactiveoxygenspecies.
11,12Incells,PQisﬁrstreducedto
form free radial monocation (PQ
+) by the reactions mediated
by a series of enzymes, including NADPH cytochrome P-450
reductase,
13 NADPH cytochrome C reductase,
14 the mitochon-
drial complex I (known as NADH), and ubiquinone oxido-
reductase.
15 Subsequently, the monocation is rapidly oxidized
while generating abundant superoxide radical (O
2 ).
16 The super-
oxide radical starts a cascade of downstream reactions leading to
the production of reactive oxygen species, mainly hydrogen
peroxide (H2O2) and hydroxyl radical (HO
 ), which cause
DNA damage or genotoxicity, destroy the lipids of cell mem-
branes, and ﬁnally induce cell death.
17
PQ is an organic cation with two positive charges and is not
metabolized in vivo.
18 PQ is predominantly eliminated by urine
and, partly, by feces.
19 The capability of organic cation transpor-
terstotransportPQacrossthebasolateralmembranefromblood
into the cell and consequently through the apical membrane
from intracellular into tubule lumina or bile duct may deter-
mine the elimination rate and retention time of PQ in vivo.
The transporters responsible for transporting organic cations
across cellular membrane include organic cation transporters
1 3 (OCT1 3), encoded by solute carrier family 22A 1 3
(SLC22A1 3),
1,20 organic cation/carnitine transporters 1 3
(OCTN1 3), encoded by SLC22A4, -5, and -21,
21 and multi-
drug andtoxin extrusion protein 1 2 (MATE1 2),encodedby
SLC47A1 and -2.
22,23 Human OCT1 is mainly expressed in the
liver,while OCT2 inthe basolateralmembrane of renalproximal
tubules.
24 In rodents, OCT1 is also abundantly expressed in the
kidney.
24 OCT3, also called extraneuronal monoamine trans-
porterforitsroleintheextraneuronalmonoamineuptakesystem
(uptake 2), is expressed ubiquitously in most tissues, but with
relatively low levels.
25 OCTNs are sodium-dependent and high-
aﬃnity carnitine transporters. The OCTN1 and OCTN2 ex-
pressed in the apical membrane of renal proximal tubules
mediate the reabsorption of carnitine and other organic cations
to maintain their plasma levels.
26 The MATE protein family,
including MATE1 and MATE2 in mammalians, has been
recently suggested to be responsible for renal or hepatic organic
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ABSTRACT: Multidrug and toxin extrusion 1(MATE1/solutecarrier 47A1)
mediates cellular transport of a variety of structurally diverse compounds.
Paraquat(PQ),whichhasbeencharacterizedinvitroasaMATE1substrate,is
awidelyusedherbicideandcancauseseveretoxicitytohumansafterexposure.
However, the contribution of MATE1 to PQ disposition in vivo has not been
determined.Inthepresentstudy,wegeneratedMate1-deﬁcient(Mate1 / )
miceandperformedtoxicokineticanalysesofPQinMate1 / andwild-type
(Mate1+/+) mice. After a single intravenous administration of PQ (50 mg/kg),
Mate1 /  mice exhibited signiﬁcantly higher plasma PQ concentrations than
Mate1+/+ mice. The renal PQ concentration was markedly increased in Mate1 /  mice compared with Mate1+/+ mice. The
subsequent nephrotoxicity of PQ were examined in these mice. Three days after intraperitoneal administration of PQ (20 mg/kg), the
transcriptlevelsofN-acetyl-β-D-glucosaminidase(Lcn2)andkidneyinjurymolecule-1(Kim-1)inthekidneywereremarkablyenhancedin
the Mate1 /  mice. This was accompanied by apparent diﬀerence in renal histology between Mate1 /  and Mate1+/+ mice. In
conclusion, we demonstrated that Mate1 is responsible for renal elimination of PQ in vivo and the deﬁciency of Mate1 function confers
deteriorated kidney injury caused by PQ in mice.
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cation elimination or secretion using a H
+-coupled antiport
mechanism.
27,28
Limited in vitro evidence has suggested that hOCT2, not
hOCT1 or hOCT3, hMATE1 and rMATE1 transport PQ in a
time- and dose-dependent manner in the overexpression models
of HEK-293 cells.
29 However, the involvement of these organic
cation transporters in the disposition and toxicity of PQ in vivo
remains undeﬁned. In this study, we generated the mouse model
of Mate1 deﬁciency (Mate1 / ) by the gene trap technique.
The toxicokinetics and toxicity of PQ were examined in the
Mate1 /  and the wild-type mice. Our data indicated that
Mate1 played a critical role in the renal elimination of PQ and
disruption of Mate1 function remarkably potentiated PQ ne-
phrotoxicity in mice.
’EXPERIMENTAL SECTION
Materials. Paraquat hydrochloride was purchased from Sig-
ma-Aldrich Co (St. Louis, MO). Paraquat [methyl-
14C] dichlor-
ide hydrate (0.1 mCi/mmol) was purchased from American
Radiolabeled Chemicals Inc. (St. Louis, MO). [
14C]-Metformin
(50 μCi, 1.85 MBq) was purchased from Moravek Biochemicals
and Radiochemicals Inc. (Brea, CA). All other reagents were
commercially available.
Generation of the Mouse Deficient of Mate1. The C57BL/
6 ES cells with the Mate1 gene trapped by a retroviral gene trap
vector at intron 10 were obtained from the Texas A&M Institute
for Genomic Medicine (TIGM, College Station, TX).
30 The ES
cells were injected into 8-cell embryos isolated from timed
pregnant C57BL/6 albino females. Injected 8-cell embryos were
cultured to blastocysts and then transferred into the uterus of
pseudopregnant females for development into individual pups.
Positive chimeric mice were identified by spotted white hairs.
The chimeric males were mated with C57BL/6 females to
generate F1 offspring from which the germ line transmission of
the target allele was confirmed by PCR method. Although the
mutant mice were derived from general C57BL/6 background,
the mice used in the present study had been backcrossed to
C57BL/6J for at least 5 generations to exclude potential subtle
genetic background effects.
Animals. All procedures were carried out in accordance with
NIH guidelines for animal experimentation, and all experimental
protocols were approved by the Institutional Animal Care and
UseCommittee(IACUC)oftheSchoolofPharmacy,University
of Maryland Baltimore. Animals were housed under controlled
conditions (21 ( 2 C, humidity 60 ( 10% and 12 h/12 hdark/
light cycle) and had free access to food and water. All animals
used in the present study were male mice with the same genetic
background of C57BL/6J, between 12 and 18 weeks of age.
Genomic DNA Extraction and Genotyping. The tail was
cut from all offsprings and genomic DNA isolated by QIAamp
DNA extraction mini kit (QIAGEN Co., Valencia, CA). The
genomic DNA was amplified with two pairs of primers to
genotype the mice (one pair for the wild-type allele and the
otherforthemutantallele:wild-type/mutantforwardprimer,50-
GAATGGGTGGGCCAAGTATG-30; wild-type reverse primer,
50-CATTGACCTGTCGTGCTGGAT-30; mutant reverse pri-
mer, 50-CTTGCAAAATGGCGTTACTTAAGC-30). The PCR
condition was as follows: an initial 3-min denaturation at 94 C,
then 94 C for 30 s, 54 C for 30 s, 72 C for 45 s for 35 cycles,
72 C for 10 min for last extension. The amplified PCR products
were separated in a 2% agarose gel and stained with ethidium
bromide.
Reverse Transcription and Real-Time PCR. Total RNA was
isolated from the liver and kidney of mice using TRIzol and
phenol chloroform method. The total RNA (2 μg) was reverse
transcribed using a high capability reverse transcipt kit (Roche
Applied Science, Indianapolis, IN). The reaction mixtures were
diluted by 4 times, and 1 μL was then used as the template for
regularPCRorreal-timePCR.TheregularPCRconditionwasas
follows: an initial 3-min denaturation step at 94 C, then 94 C
for30s,54Cfor30s,72Cfor10sfor25cycles forMate1and
glyceraldehyde-3-phosphate dehydrogenase (Gapdh)inthe liver
and kidney. The real-time PCR condition was as follows: an
initial2-minincubationstepat50C,then3-mindenaturationat
94C,followedby40cyclesof2stepsat94Cfor30sand60C
for 60 s. Real-time PCR was performed on ABI PRISM 7700
(Applied Biosystems, Foster City, CA). The expression of
biomarker genes for kidney injury, including Kim-1 and Lcn2,
and drug transporters located in the liver and kidney, including
Oct1 3,Octn1 3,Mrp1 4,Oatp1a1,Oatp1a4,Oatp1b2,Mdr1,
Bcrp, and Bsep, were determined by real-time PCR.
Function Deficiency of Mate1 in Mate1 /  Mice. Metfor-
min has been well characterized as a substrate for Mate1 in vitro
and in vivo.
31 In the previous report, metformin pharmacoki-
netics was significantly altered in the Mate1 knockout mice
created by traditional recombination gene targeting.
32 To func-
tionally validate our Mate1 /  mouse model, we determined
and compared metformin tissue distribution in these mice and
wild-type control mice. Five milligrams per kilogram metformin,
containing 0.2 μCi/mL [
14C]-metformin, was injected via tail
vein into Mate+/+ and Mate1 /  mice. At 60 min after
injection, different tissues including liver and kidney were
removed, weighed, homogenized, and centrifuged. 100 μLo f
supernatant was added into scintillation buffer and counted in a
multipurpose scintillation counter (Beckman LS6500 Counter,
Brea, CA) to determine tissue accumulation of metformin.
PQToxicokinetics.Inhumans,moderate-to-severepoisoning
is usually secondary to ingestion of 20 50 mg/kg PQ.
33 In this
study, Mate1+/+ and Mate1 /  mice were injected by tail
vein with 50 mg/kg PQ as described elsewhere.
18,33 35 PQ
was dissolved in 0.9% saline (the ratio of total paraquat to
[
14C]-PQwas130:1).Bloodsampleswerecollectedbytailbleeding
at 5, 10, 20, 30, 60, and 90 min after injection. The radioactivity in
20 μL of blood was counted in a multipurpose scintillation counter
(Beckman LS6500 counter, Brea, CA). The mice were sacrificed
at 90 min, and the tissues were isolated, gently washed, weighed,
submerged in phosphate buffered saline, pH 7.4, and further
homogenized completely. The homogenized tissues were centri-
fuged at 15000 rpm for 10 min and the radioactivity in the
supernatant was counted.
Determination of Toxicokinetic Parameters. WinNonlin
version 5.2.1 (Pharsight Corporation, Mountain View, CA) was
used to analyze the plasma concentration time profiles of PQ
after the intravenous administration in mice. Toxicokinetic
parameters and the area under the blood concentration time
curve from time 0 to infinity (AUC∞) were calculated by the
nonlinearleast-squaresmethod.TheAUCuntil90min(AUC0 90)
was determined by the trapezoidal rule.
PQTissueToxicity.Fortissuetoxicityexperiments,Mate1+/+
and Mate1 /  mice were injected with 20 mg/kg PQ as
described elsewhere.
34,35 PQ was dissolved in 0.9% saline and
injectedip. The mice weresacrificed at72 hafterinjection. Total2478 dx.doi.org/10.1021/mp200395f |Mol. Pharmaceutics 2011, 8, 2476–2483
Molecular Pharmaceutics BRIEF ARTICLE
RNA was extracted from one kidney. The expression of Lcn2
and Kim-1 genes, as indicators of acute kidney injury,
36,37
were determined by real-time PCR as described above. For
histopathological analysis, the other kidney and the liver were
collected and submerged immediately into 10% formalin saline
buffer overnight, and further processed to paraffin embedding
and hematoxylin and eosin (H&E) staining.
Statistical Analysis. All data were expressed as the mean (
standarddeviation(SD).Datafromreal-timePCRwereanalyzed
statistically with the one-way analysis of variance (ANOVA)
followedbyDunnett’stest.Datafrombloodbiochemicalanalysis
and toxicokinetic analysis were analyzed statistically using the
unpaired Student’s t test. A P value of <0.05 was considered
statistically significant.
’RESULTS
Disruption of the Mate1 Gene by a Gene Trap Vector in
Mice. In order to understand the physiology and pharmacology
significance of Mate1, we generated a Mate1 mutant mouse
strain.Themicewerederivedfromanembryonicstemcelllineof
mutated C57BL/6 ES cell library created by gene trapping in the
Texas A&M Institute for Genomic Medicine (TIGM, College
Station, TX).
30 The ES cell line was integrated with a retrovirus
vector containing the 50 selectable marker β-geo, a functional
fusion between the β-galactosidase and neomycin resistance
genes, in the intron 10 of Mate1 genomic locus (Figure 1A).
Chimeric mice were first generated from ES cells and then
m a t e dw i t hw i l d - t y p eC57BL/6J mice, resulting in germ line
transmission. A PCR-based genotyping assay was established to
distinguish wild-type, heterozygous, and homozygous mice
(Figures 1A and 1B). Heterozygous mice were intercrossed to
generate enough wild-type mice and homozygous mutant mice
for the following experiments. The Mate1 transcript level was also
determined by real-time PCR in RNA samples from mouse kidney.
There was at least 90% reduction in Mate1 expression in the kidney
of mutant mice compared to the wild-type mice (Figure 1C).
PhenotypicCharacterization.Wemonitoredallthemicefor
atleast3months.Wefoundthattherewasmodestbutsignificant
difference in body weight between the wild-type and homozy-
gous mutant mice at 3 months of age (wild-type 25.9 ( 1.14 g vs
mutant 30.18 ( 1.57 g, P = 0.03, n = 5). We did not detect any
other overt phenotypes in the homozygous mutant animals.
Homozygousmutantmicewereobservedtobeviableandfertile,
consistent with previous results of the Mate1 knockout mice
created by gene targeting using homologous recombination.
32
Metformin is a well characterized substrate for Mate1.
38 The
accumulationofmetforminhasbeenpreviouslydemonstratedto
be significantly different between wild-type and Mate1 knockout
mice.
32 In the present study, the accumulation of metformin in
the liver and kidney was determined to functionally validate our
mouse model. At 60 min after an intravenous dose of 5 mg/kg
metformin, hepatic and renal accumulation was 6.9- and 3.4-fold
higher in the homozygous mutant mice than in the wild-type
control mice, respectively (P < 0.05, Figure 2). The results were
comparable to those obtained by others between Mate1 knockout
miceandwild-typemice.
32Basedontheresultsfromgenotyping,
transcript and function measurement, we concluded that the
Mate1 gene was effectively disrupted in our homozygous mutant
mice, which are therefore designated as Mate1 /  mice.
Drug Transporter Gene Expression in Mate1 /  and
Mate1+/+ Mice. To clarify whether mRNA levels of other drug
transporter genes, in particular organic cation transporter genes,
are altered in Mate1 /  mice, the mRNA expression of main
Figure 1. Generation of Mate1-deﬁcient mice via gene trapping. (A)
Schematicofgenetrappingandgenotypingstrategy.Forwardandreverse
primers are located in intron 10 of Mate1 genomic locus; V76 reverse
primerlocatedinbackboneofthetrappingvector(OmnibankGeneTrap
Vector76).
30(B) PCR-basedgenotypingdistinguisheswild-type,hetero-
zygous, and homozygous animals. Two polymerase chain reactions (PCR)
are needed for genotyping every mouse. The two PCR products were
mixed equally and separated at 2% gel with ethidium bromide staining.
(C) Transcript levels of Mate1 in Mate1+/+ and Mate1 /  male mice.
The mRNA level shown is relative to that of Gapdh. ***P < 0.001
Figure2. MetforminaccumulationintheliverandthekidneyofMate1+/+
mice and Mate1 /  mice. The Mate1+/+ (white bar) and Mate1 /
  (black bar) mice were sacriﬁced at 60 min after the administration of
5 mg/kg metformin containing 0.2 μci/ml [
14C]-metformin via tail vein
injection. Each barrepresents the mean (SDfor 6male mice. ***P<0.0 01
signiﬁcantly diﬀerent from Mate1+/+ mice.2479 dx.doi.org/10.1021/mp200395f |Mol. Pharmaceutics 2011, 8, 2476–2483
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transporters in the kidney and liver was determined by real-time
PCR.ExceptthatAbcb1aexpressionwaselevatedby150%inthe
liver of Mate1 /  mice (Figure 3), there was no difference in
theexpressionofothertransportergenesbetweenMate1+/+and
Mate1 /  mice (data not shown).
ToxicokineticsofPQinMate1+/+andMate1 / Mice.We
compared the toxicokinetics of PQ (50 mg/kg), a substrate of
Mate1identifiedinvitro,
29inMate1 / andMate1+/+mice.The
plasmaconcentrationsofPQweremarkedlyelevatedinMate1 / 
mice compared with Mate1+/+ mice (Figure 4A). The
AUC0 90min for PQ in Mate1 /  was significantly increased
64%whencomparedwiththatinMate1+/+mice(5530(394vs
3380 ( 216 μg3min/mL, P = 0.005). Cmax in Mate1 /  and
Mate1 +/+ was 127 ( 13.4 and 80.5 ( 21.7 μg3mL/mg,
respectively, increasing 57% in the Mate1 /  mice (P = 0.03).
The difference of Tmax between Mate1 /  (84.2 ( 11.4 min)
and Mate1+/+ (61.8 ( 15.2 min) did not reach a statistical
significance (P = 0.06). The toxicokinetic parameters were sum-
marized in Table 1. The accumulation of PQ in the major tissues
including lung, liver and kidney were also measured after the
single dose. The renal accumulation of PQ in Mate1 /  mice
was increased by 147% as compared to the Mate1+/+ mice (P =
0.014). In the lung, PQ accumulation was elevated by 59.5% in
Mate1 / mice(P=0.03).However,therewasareversedtrend
regarding PQ accumulation in the liver. The hepatic accumula-
tion of PQ tended to be lower in Mate1 /  mice than in Mate1
+/+ mice (P = 0.16) (Figure 4B). Although PQ accumulation
tended to be higher in other tissues such as brain, the differences
did not reach statistical significance (data not shown).
PQ Toxicity in Mate1+/+ and Mate1 /  Mice. T h em i c eo f
different Mate1 genotypes (Mate1+/+ and Mate1 / )w e r ei n -
jected ip with 20 mg/kg PQ. The respiration and behavior activities
were observed for 72 h after PQ administration. Mate1 /  mice
exhibited more difficult respiration, less movement, and decreased
bodyweightincomparisontoMate1+/+mice(datanotshown).All
mice were sacrificed at 72 h. The total RNA was extracted from the
kidneyandliver.ThetranscriptlevelsoftheKim-1andLcn2genes,as
indicators of acute kidney injury,
36,37 were determined. Lcn2 expres-
s i o nw a sa p p a r e n t l ye l e v a t e db yP Qt r e a t m e n t ,w i t hm u c hm o r e
dramatic increase in the Mate1 /  mice when compared with
Mate1+/+ by over 40-fold (P < 0.001). Similarly, Kim-1 expression
was27-foldhigherintheMate1 / micethanthatintheMate1+/+
mice after PQ treatment(P<0.001) (Figures5A and 5B).Thedata
indicated that PQ caused more severe acute kidney injury in
Mate1 /  mice than in Mate1+/+ mice.
Histopathologic evaluation of kidneys from PQ-treated mice
demonstrated much more severe necrosis containing eosinophilic
amorphous material and pyknotic debris (depicted by arrows
in Figure 6B) in Mate1 /  mice than in Mate1+/+ mice. In
addition, Mate1 /  kidney showed degeneration including tub-
ular dilatation, tubular cell vacuolation, and tubular cell detach-
ment from basement membrane after the PQ treatment. In the
liver, the damageby PQ alsoshowedthe sametrend asthat in the
kidney between the two genotypes (Figures 7A and 7B). There
was no obvious damage in the liver of Mate1+/+ mice, while in
Mate1 / mice,balloonhepatocytesandapoptoticnecroticcells
adjacent to the central vein existed and the basal membrane
adjacent to the central vein was inconsecutive and broken.
Figure3. HepaticAbcb1atranscriptlevelsinMate1+/+andMate1 / 
mice. ThemRNA level shownisrelative to the transcript level ofGapdh.
*P < 0.05, signiﬁcantly diﬀerent from Mate1+/+ mice.
Figure 4. PQ toxicokinetics in the mice of diﬀerent Mate1 genotypes.
(A) The plasma concentration proﬁle of PQ in Mate1 /  (2) and
Mate1+/+ (9) mice. 50 mg/kg PQ in saline was administered via tail
veininjection.Bloodsampleswerecollectedatthetimepointsindicated.
PQ levels in the blood samples were determined by counting
14C-PQ
(the ratio of labeled to total PQ is 1:130). Each point represents the
mean ( SD for 6 male mice. *P < 0.05; **P < 0.01; ***P < 0.001,
signiﬁcantly diﬀerent from Mate1+/+ mice. (B) PQ accumulation in
diﬀerent tissues from Mate1+/+ mice (white bar) and Mate1 /  mice
(black bar) at 90 min after 50 mg/kg PQ administration via tail vein
injection.Eachbarrepresentsthemean(SDfor6malemice.*P<0.05;
**P < 0.01, signiﬁcantly diﬀerent from Mate1+/+ mice.
Table 1. Toxicokinetic Parameters of PQ in Mate1+/+ and
Mate1 /  Mice after 50 mg/kg PQ Injection via Tail Vein
parameters Mate1+/+ Mate1 /  P value
AUC0 90 (μg3min/mL) 3380 ( 216 5530 ( 394 0.005
AUC0 ∞ (μg3min/mL) 7000 ( 2200 9530 ( 2230 0.16
Cmax (min) 80.5 ( 21.7 127 ( 13.4 0.03
Tmax (μg/m) 61.8 ( 15.2 84.2 ( 11.4 0.06
T 1/2 (min) 64.5 ( 9.3 55.2 ( 14.4 0.672480 dx.doi.org/10.1021/mp200395f |Mol. Pharmaceutics 2011, 8, 2476–2483
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’DISCUSSION
Inthe presentstudy,themousemodelof Mate1deﬁciencywas
successfully established via the gene trap technology. Successful
gene trapping was conﬁrmed by using the primers speciﬁct ot h e
trap vector and to the Mate1 genomic locus. Mate1 transcripts
were rarely detected in the kidney and liver of Mate1 /  mice,
two tissues with high Mate1 expression inwild-typemice.
37Using
metformin as a probe substrate, our Mate1 /  mice exhibited
loss of Mate1 transporter function that was comparable to a
previous Mate1 knockout mouse model created by conventional
targeting recombination.
32Wedid notdetectanyalterationinthe
expression of other transporters, including those transporting
organic cations, except Abcb1a encoding P-glycoprotein (P-gp)
in the liver. The mouse model of Mate1 deﬁciency should be an
appropriate tool to characterize the disposition of the xenobiotics
interacting with MATE1 in vivo.
PQ, a widely used herbicide, is rapidly distributed into tissues
and accumulated in the lung, liver and kidney with high con-
centrations, resulting in serious toxicity in these organs. The
kidneyismainlyresponsiblefortheeliminationofmostsystemic
PQ with minor contribution from the liver.
18,39 In order to treat
patients with PQ poisoning, it is critical to understand the
mechanism of PQ elimination in the kidney and preserve renal
function. In the in vitro overexpression system of HEK-293 cells,
PQ has been characterized as a substrate toward OCT2 and
MATE1.
29 Human OCT2 is primarily expressed at the basolat-
eral membrane andisresponsibleforthe entry oforganic cations
into the renal proximal tubular cells.
1 In contrast, MATE1 is
located in the brush-border membrane and responsible for the
second step of renal secretion of organic cations. In the present
study, we sought to determine the role of Mate1 in determining
PQ disposition and toxicity in vivo by using our established
Mate1 /  mouse model. We performed the toxicokinetics of
PQinMate1 / miceandMate1+/+mice.Theconcentrations
of PQ in the blood were markedly higher in Mate1 /  mice
comparedwithMate1+/+mice,alongwithsigniﬁcantdiﬀerences
in multiple toxicokinetic parameters. The data indicate that
Mate1 plays a critical role in PQ disposition. It should be noted
that the Mate1 /  mice gained more body weight at 3 months
Figure6. Histopathologicchangesinthekidneyfromthemicereceived
PQ treatment. The Mate1+/+ (A) and Mate1 /  (B) mice were
treatedwitha20mg/kgsingleipdosefor72h.Mate1 / kidneyshows
severnecrosiscontainingeosinophilicamorphousmaterialandpyknotic
debris (white arrows). The black scale bar represents 10 μm.
Figure5. Renaltranscriptlevelsofthebiomarkergenesforacutekidney
injuryinthemicereceived PQtreatment.(A)Lcn2transcriptlevels.(B)
Kim-1 transcript levels, in the kidney of Mate1+/+ (white bar) and
Mate1 / (blackbar)genotypes,respectively.ThemRNAlevelshown
is relative to Gapdh transcript level. ***P < 0.001, signiﬁcantly diﬀerent
from Mate1+/+ mice.2481 dx.doi.org/10.1021/mp200395f |Mol. Pharmaceutics 2011, 8, 2476–2483
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ofagethanwild-typemice.Thereasonremainstobedetermined.
Currently, there were no reports on eﬀect of body weight on PQ
disposition. In this study, PQ was dosed based on the body
weight and the reported diﬀerences between Mate1 /  mice
and wild-type mice had been normalized with body weight,
suggesting that the toxicokinetic diﬀerences between the two
genotypes are not secondary to the body weight diﬀerence.
PQ accumulation in the kidney and lung, two of the major
organs responsible for PQ acute toxicity, was signiﬁcantly higher
for the Mate1 /  mice than for the Mate1+/+ mice after an
acute single dose of 50 mg/kg. However, unexpectedly, PQ
accumulation in the liver, another major organ responsible for
PQ toxicity, tended to, while not signiﬁcantly, be lower for the
former after the acute dose. Since the hepatic accumulation of
metformin,aprobesubstrateofMate1,
38issigniﬁcantlyhigherin
the mice deﬁcient of Mate1 function,
32 we speculate that the
diﬀerence in hepatic PQ accumulation between Mate1 /  and
Mate1+/+ mice was secondary to Mate1 deﬁciency. One possi-
bilityisthatMate1deﬁciencycausedfunctionalchangesforother
PQ transporters in the liver. We detected the transcript levels of
multiple drug transporter genes in the livers and kidneys from
Mate1 / andMate1+/+micewithandwithoutPQtreatment.
WhilePQtreatmentseemedtodownregulateseveraltransporter
genes in the kidney and liver of both Mate1+/+ and Mate / 
mice, only hepatic Abcb1a was found to be diﬀerently expressed
between these two mice, with Mate1 /  mice showing 150%
higher expression. P-gp, encoded by Abcb1a in mice, is an ATP-
driventransmembranetransportercapableoftransportingawide
variety of structurally diverse and functionally unrelated com-
pounds out of the cell.
40 Dinis-Oliveira et al. have reported that
the induction of de novo synthesis of P-gp by dexamethasone
decreases PQ lung accumulation and consequently its toxicity.
41
On the other hand, verapamil, a competitive inhibitor of this
transporter, when given one hour before dexamethasone,
blocked these protective eﬀects and caused an increase of PQ
lung concentration and an aggravation in toxicity.
42 It is thus
likelythattheincreasedAbcb1aexpressionwasabletoovercome
Mate1 deﬁciency and responsible for the less or unaltered PQ
accumulation in the Mate1 /  mice during the studied time.
However,thishypothesisneedstobefurthertested.Inparticular,
it is necessary to directly conﬁrm PQ as a P-gp substrate and
determine the mechanism of hepatic Abcb1a upregulation sec-
ondary to Mate1 deﬁciency. It should be noted that Mate1 / 
mice still exhibited more severe hepatoxicity than Mate1+/+
miceafterthreedays ofPQexposure,whichmaybeexplainedby
a much higher systemic PQ exposure over time and/or severe
toxicity in other critical organs including kidney and lung.
PQ poisoning can cause acute kidney injury (AKI).
3 Kid-
neyinjurymolecular-1 protein(Kim-1),
36,43andlipocalin2gene
(Lcn2), encoding neutrophil gelatinase-associated lipocalin
(NGAL),
37,44 have been demonstrated to be highly upregulated
during AKI. They are both primarily potential biomarkers of the
earlystage ofAKIinrodentsandhumans.
36,37 Wefound thatthe
mRNA expression of Kim-1 and Lcn2 genes were elevated
dramatically in the Mate1 /  mice treated by 20 mg/kg PQ
forthreedays,withonlymarginalincreasedetectedintheMate1+/+
mice. Moreover, the histology of kidney and liver showed
more severe damage in Mate1 /  mice when compared to
Mate1+/+mice.Wealsoobservedapparenttoxicsymptomssuch
as respiration diﬃculty and body weight loss in Mate1 /  mice
but not in Mate1+/+ mice. These results, coupled with the
toxicokinetic ones, indicated that Mate1 played a critical role in
PQ-induced acute toxicity including AKI by modulation of PQ
eliminationinthekidney.Inhumans,MATE1ishighlyexpressed
in the kidney and the liver. MATE2 (MATE2-K) exhibits a
kidney-speciﬁc expression. MATE1 and MATE2 are detected
at similar mRNA levels in human kidney. In mice, Mate1 is
highly expressed in both the kidney and the liver. The
tissue distribution of Mate1 in mice is generally consistent with
Figure 7. Histopathologic changes in the liver from the mice received
PQ treatment. The Mate1+/+ (A) and Mate1 /  (B) mice were
treated with a 20 mg/kg single ip dose for 72 h. Mate1 /  liver shows
balloon hepatocytes and apoptotic necrotic cells adjacent to the central
vein and the basal membrane adjacent to the central vein was in-
c o n s e c u t i v ea n db r o k e n( w h i t ea r r o w s ) .T h eb l a c ks c a l eb a rr e p r e -
sents 10 μm.2482 dx.doi.org/10.1021/mp200395f |Mol. Pharmaceutics 2011, 8, 2476–2483
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that in humans. However, MATE2 is not expressed in mice.
Therefore, inthecaseofMATE, Mate1 / micemayrepresent
a model of deﬁciency in both MATE1 and MATE2 in human
kidney.
32
Previous data suggest a positive dose response relationship
betweenlifetimecumulativeexposuretoPQandriskofPD.
45 47
Future studies are warranted to use the Mate1 /  mice to
determinetheroleofMate1inPQ-inducedchronictoxicitysuch
as PD risk. Our data suggest that the toxic response to PQ in
patients may vary because of diﬀerent activity of MATE and that
we should avoid the drugs and factors inhibiting MATE function
when treating these patients. For example, patients with certain
genetic variants of MATE including MATE1 and MATE2 may
have diﬀerent susceptibility to PQ toxicity. Two variants of
human MATE1 with no function and four with altered function
have been reported.
48,49 Three of them were polymorphic in
a particular ethnic population with allele frequencies greater
than 2%. Clinical signiﬁcance of human MATE polymor-
phisms in PQ-associated symptoms and diseases merits further
investigation.
Insummary,wegeneratedamousemodelofMate1functional
deﬁciency by gene trapping. The mouse model can be used to
characterize in vivo xenobiotic disposition and explore Mate1
physiology. By using this model, we have demonstrated for the
ﬁrst time that the Mate1 transporter plays a critical role in the
renal elimination of PQ in mice and in conferring PQ toxicity.
Future studies are required to deﬁne the eﬀect of MATE
transporter function on PQ toxicity in humans.
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